Society

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and …

Local Covid vaccines fill gap as UN Covax scheme misses target Read More »

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa. Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom …

WHO endorses use of world’s first malaria vaccine in Africa Read More »

Covid antiviral pill halves hospitalisations and deaths, maker says

If approved, Merck’s drug would be first simple oral medication shown to be effective against coronavirus Coronavirus – latest updates See all our coronavirus coverage The first pill to treat coronavirus could be available within months after it was found to cut hospitalisations and deaths by half. If approved, the antiviral drug would be the …

Covid antiviral pill halves hospitalisations and deaths, maker says Read More »

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters

Fragmented care means patients can be put on drugs by many different specialists, says Charles Warlow, while Dr Wendy Outwin highlights the daily reality of prescribing medicines Ministers seem to have found yet another way to bash overburdened GPs (Government review finds 10% of drugs dispensed in England are pointless, 22 September). There is nothing …

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters Read More »

Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad • Coronavirus – latest updates• See all our coronavirus coverage England’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British …

Ministers told to bar EU from UK trial data in vaccines row Read More »

UK cancels Covid vaccine deal with French firm Valneva

Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to …

UK cancels Covid vaccine deal with French firm Valneva Read More »

BioNTech to seek approval for Covid jabs for younger children

Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have …

BioNTech to seek approval for Covid jabs for younger children Read More »

UK approves rollout of ‘first of its kind’ Covid antibody treatment

Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19. The health secretary, Sajid Javid, said approval of the first drug …

UK approves rollout of ‘first of its kind’ Covid antibody treatment Read More »

Drug firms poised to make billions of dollars from Covid booster jabs

Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts Coronavirus – latest updates See all our coronavirus coverage The drug companies Pfizer, BioNTech and Moderna are poised to make billions of dollars from Covid-19 booster jabs this autumn, with analysts estimating that sales could rival the $6bn-a-year market …

Drug firms poised to make billions of dollars from Covid booster jabs Read More »

UK orders extra Covid vaccines for autumn 2022 booster campaign

Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited Coronavirus – latest updates See all our coronavirus coverage Ministers have started ordering vaccines for a booster campaign in autumn 2022, with Pfizer reportedly being asked to supply the UK with a further 35m doses. The government has …

UK orders extra Covid vaccines for autumn 2022 booster campaign Read More »

Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs

Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the NHS for vital anti-epilepsy drugs by abusing their dominance in the market to raise prices overnight. The Competition and Markets Authority (CMA) has confirmed …

Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs Read More »

Drug firm that hiked prices by 6,000% paid shareholders £400m

Advanz Pharma and former private equity owners were fined £100m by markets watchdog A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period. London-based Advanz Pharma – and its former private equity owners HgCapital and Cinven – …

Drug firm that hiked prices by 6,000% paid shareholders £400m Read More »

Price gouging fine for Advanz is a rare story that is becoming common | Phillip Inman

Competition and Markets Authority is working on a string of cases involving the NHS being overcharged for drugs A fine by the Competition and Markets Authority (CMA) for unfair pricing by private health companies is a rare story that looks set to become increasingly common. This week’s example is the £100m penalty dished out to …

Price gouging fine for Advanz is a rare story that is becoming common | Phillip Inman Read More »

Is medical cannabis really a magic bullet?

Research increasingly suggests that extracts from the plant are effective in treating pain, anxiety, epilepsy and more, but experts still preach caution around recreational use In 2017, Mikael Sodergren, a liver and pancreatic cancer surgeon at Imperial College healthcare NHS trust, was finding himself becoming increasingly interested in the potential role of medical cannabis in …

Is medical cannabis really a magic bullet? Read More »

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams

On morning TV this week, two of the developers of the Oxford vaccine were faced with an outpouring of thanks. It was very much deserved – and very hard for them to reply I don’t watch much TV in the morning – I put it roughly on a par with smoking weed in the morning …

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams Read More »

Million Pfizer jabs face being dumped after Israel-UK swap deal fails

Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July Coronavirus – latest updates See all our coronavirus coverage More than a million Pfizer/BioNTech vaccine doses held in Israel that are due to expire at the end of July may be thrown away after attempts to broker a swap …

Million Pfizer jabs face being dumped after Israel-UK swap deal fails Read More »

‘Johnson & Johnson helped fuel this fire’ – now it’s out of the opioids business

Whether the pharmaceutical giant jumped or was pushed, its New York deal is a significant sign of the way the wind is blowing Johnson & Johnson said it had already jumped. New York’s attorney general suggested the pharmaceutical giant was pushed. Either way, the American drug maker is the first to formally agree to get …

‘Johnson & Johnson helped fuel this fire’ – now it’s out of the opioids business Read More »

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy

Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude is at the heart of the conversation Last week, I had cause to go searching for images of men getting vaccinated (it’s not a fetish – it was for work) …

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy Read More »

Covid jabs for billions of humans will earn their makers billions of dollars

We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive Coronavirus – latest updates See all our coronavirus coverage Drugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this …

Covid jabs for billions of humans will earn their makers billions of dollars Read More »

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now?

Having built a big operation during the pandemic it could stick or twist but either way investors will soon want a decision What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses, will keep signing partnerships and will try to ignore churlishness in …

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now? Read More »

More research funding needed to avoid drug-resistant pandemic, warns report

Smaller firms are developing most antibiotics targeting superbugs but often at risk of bankruptcy Small drugmakers and biotech firms that are developing the bulk of new antibiotics need far more financial support, according to a new report, which warned that without these life-saving medicines there could be a pandemic of drug-resistant infections, worse than Covid-19. …

More research funding needed to avoid drug-resistant pandemic, warns report Read More »

Thailand starts Covid vaccine drive using jabs made by king’s firm

Country aims to vaccinate 70% of people this year but experts express doubts amid supply concerns Coronavirus – latest updates See all our coronavirus coverage Thailand has started its Covid vaccination campaign amid concerns over the supply of doses, which are mainly being produced locally by a royal-owned company that has no prior experience of …

Thailand starts Covid vaccine drive using jabs made by king’s firm Read More »

Helen Murray Free obituary

Chemist who transformed medical screening by developing glucose dipsticks In the 1950s the US chemist Helen Murray Free, who has died aged 98, was responsible for developing glucose dipsticks. Their use led to much simpler medical screening methods that are still widely used today for pregnancy tests, the diagnosis and monitoring of diabetes, and to …

Helen Murray Free obituary Read More »

Taiwan accuses China of interfering with Covid vaccine deals

President says agreement with German firm BioNTech has been delayed after Beijing intervention Coronavirus – latest updates See all our coronavirus coverage Taiwan’s president has accused China of interfering in its vaccine acquisition programme, as the island continues to battle hundreds of daily new cases of Covid-19 with low supplies of vaccines. Taiwan has received …

Taiwan accuses China of interfering with Covid vaccine deals Read More »

UK pharmaceutical firm Ventura agrees to £958m takeover deal

Private equity firm Carlyle Group to buy company that is developing inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group as it looks set to become the latest …

UK pharmaceutical firm Ventura agrees to £958m takeover deal Read More »

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote

Investors are lining up to oppose pay-and-perks plan for Pascal Soriot worth up to £17.8m for 2021 AstraZeneca could be forced to rip up plans to boost the pay of its chief executive, Pascal Soriot, as investors prepare to vote on proposals that could take his remuneration after nearly a decade at the helm of …

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote Read More »

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs

Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus Coronavirus – latest updates See all our coronavirus coverage The UK has ordered a further 60m doses of the Pfizer/BioNTech Covid vaccine in an effort to ensure that booster jabs can be given from this autumn, the government has announced. The …

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs Read More »

What Covid vaccines does the UK have and which are in the works?

As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See all our coronavirus coverage Vaccines to protect against the coronavirus were designed, tested and manufactured in record time, and several have been approved for use in the UK vaccination programme, …

What Covid vaccines does the UK have and which are in the works? Read More »

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi

Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses for nations in the global south. It has approached AstraZeneca …

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi Read More »

Will Covid vaccines protect us against new variants? | Julian Tang

New strains such as the South African variant that’s emerged in south London will require constant vigilance as lockdown eases All viruses mutate. They do this to adapt and survive better in their specific host. The virus that causes Covid-19 is no different: it has moved from the animal realm, where it most likely originated …

Will Covid vaccines protect us against new variants? | Julian Tang Read More »

Global Covid vaccine rollout threatened by shortage of vital components

Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s …

Global Covid vaccine rollout threatened by shortage of vital components Read More »

Coronavirus: UK expert urges people in 20s to keep getting vaccine

Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine because of the wider benefit to their families, friends and …

Coronavirus: UK expert urges people in 20s to keep getting vaccine Read More »

UK ministers silent on AstraZeneca vaccine shipment to Australia

Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few …

UK ministers silent on AstraZeneca vaccine shipment to Australia Read More »

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam

England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus vaccine, given adults in that age group are now being …

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam Read More »

AstraZeneca jab: UK government says concerns being investigated thoroughly

People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very thoroughly” investigated, before an imminent announcement by the vaccines regulator. …

AstraZeneca jab: UK government says concerns being investigated thoroughly Read More »

AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed …

AstraZeneca Covid vaccine: weighing up the risks and rewards Read More »

Two new vaccines on the way – with more to follow this year

Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with more than half of the country’s adult population having now …

Two new vaccines on the way – with more to follow this year Read More »

Pfizer vaccine has 91% efficacy for up to six months, trial shows

Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to six months, an updated analysis of clinical trial data has …

Pfizer vaccine has 91% efficacy for up to six months, trial shows Read More »

Pfizer finds Covid vaccine safe and effective for children 12 to 15

Drug firm in partnership with BioNTech to seek US approval after trials found vaccine ‘well-tolerated’ in school-age children Pfizer plans to seek emergency approval for its Covid vaccine in younger people after a US trial found the jab prevented the disease and was “well-tolerated” in 12- to 15-year-olds. Related: Germany restricts use of AstraZeneca jab …

Pfizer finds Covid vaccine safe and effective for children 12 to 15 Read More »

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn

The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of the shining stars of the pandemic. Not only did it produce a vaccine where other big players failed, the UK-Swedish company has pledged to sell it at cost until it …

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn Read More »

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK

Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a week Coronavirus – latest updates See all our coronavirus coverage The AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s most famous modern scientists and turned the Anglo-Swedish pharmaceutical company …

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK Read More »

Vaccine wars: the week that rocked the UK’s Covid jab rollout

After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been …

Vaccine wars: the week that rocked the UK’s Covid jab rollout Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

What price a child’s life? India’s quest to make rare disease drugs affordable

Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated. Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that …

What price a child’s life? India’s quest to make rare disease drugs affordable Read More »

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, …

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns Read More »

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering across the world. Now more than ever, we must remember …

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot Read More »

BioNTech co-founder says gender equality made vaccine possible

Özlem Türeci credits firm’s more than 50% female workforce for speed at which first viable jab created The co-founder and chief medical officer of BioNTech has credited its speed at producing a viable vaccine to the fact its workforce is more than 50% female. Speaking on International Women’s Day, Özlem Türeci also said the fact …

BioNTech co-founder says gender equality made vaccine possible Read More »

NHS to use world’s most expensive drug to treat spinal muscular atrophy

Zolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time The world’s most expensive drug, which treats babies and young children with a rare and often fatal degenerative disorder, will be available this year for the first time on the NHS in England. Zolgensma, which costs £1.79m …

NHS to use world’s most expensive drug to treat spinal muscular atrophy Read More »

From Pfizer to Moderna: who’s making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for …

From Pfizer to Moderna: who’s making billions from Covid vaccines? Read More »

Thalidomide scandal: Sunak pledges lifetime support for survivors

Joy and relief from campaigners as chancellor’s budget extends support that had been due to run out in 2023 Analysis: Sunak digs in for battle against financial cost of Covid Budget 2021: key points at a glance Budget 2021 live: Sunak to freeze income tax thresholds Thalidomide campaigners have reacted with relief and joy after …

Thalidomide scandal: Sunak pledges lifetime support for survivors Read More »

Pfizer vaccine may be less effective in people with obesity, says study

Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with obesity produced only about half the amount of antibodies in …

Pfizer vaccine may be less effective in people with obesity, says study Read More »

Life-extending drug for incurable breast cancer approved for NHS use

About 3,300 women a year may benefit from decision to approve ribociclib Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance. The National Institute for Health and Care Excellence (Nice) has approved the drug – …

Life-extending drug for incurable breast cancer approved for NHS use Read More »

Vaccine clinical trials for Covid variants to start in summer, MPs told

Updated versions of vaccine are being developed in case variants evade immunity provided by current shots Coronavirus – latest updates See all our coronavirus coverage Clinical trials of vaccines against new variants of coronavirus will start in the summer to ensure updated boosters are available for the autumn if needed, Oxford’s lead vaccine researcher has …

Vaccine clinical trials for Covid variants to start in summer, MPs told Read More »

Number of UK Covid vaccinations falls by a third as vaccine supply dips

Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all our coronavirus coverage The number of Covid vaccines administered in the UK has fallen by over a third in the last week as ministers warned of a short-term dip in …

Number of UK Covid vaccinations falls by a third as vaccine supply dips Read More »

South Africa leads backlash against big pharma over access to Covid vaccines

Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major pharmaceutical companies needs to be confronted to provide fairer access to vaccines, a leading South African official has said. The scramble over Covid vaccines should alert rich countries to the …

South Africa leads backlash against big pharma over access to Covid vaccines Read More »

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence

From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from …

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence Read More »

CBD will go on sale in Australia, but first manufacturers will have to prove it works

While CBD has been approved for over-the-counter sale, there are regulatory hurdles to clear before it actually appears in pharmacies “You can have as much whiskey as you like, but there’s no whiskey available,” says Prof Iain McGregor, psychopharmacologist and academic director of the Lambert Initiative for Cannabinoid Therapeutics, when asked to describe the rules …

CBD will go on sale in Australia, but first manufacturers will have to prove it works Read More »

Oxford Covid vaccine just as effective against Kent variant, trials suggest

Scientists behind AstraZeneca vaccine say it has similar efficacy against variant as against original Covid Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca coronavirus vaccine is just as effective at fighting the UK variant as it is the original virus, new research suggests. Oxford University researchers who developed the vaccine say it …

Oxford Covid vaccine just as effective against Kent variant, trials suggest Read More »

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they plan to work jointly to develop a vaccine that can …

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine Read More »

Teesside ‘buzzing’ that Novavax vaccine will be made there

Area that has suffered industrial decline proud to play key role in fight against coronavirus Coronavirus – latest updates See all our coronavirus coverage The legend “made on Teesside” has a long and proud history, with everything from the Sydney Harbour Bridge to the Quorn in vegan sausage rolls manufactured in this industrial part of …

Teesside ‘buzzing’ that Novavax vaccine will be made there Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet

Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement Coronavirus – latest updates See all our coronavirus coverage I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first …

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet Read More »

Vaccine experts defend UK decision to delay second Pfizer Covid jab

Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned that the strategy was proving “ever-more difficult to justify”. The …

Vaccine experts defend UK decision to delay second Pfizer Covid jab Read More »

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the UK stays locked down. All depends on how fast the …

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty Read More »

UK vaccine minister vows ‘massive uplift’ in number of jabs this week

Nadhim Zahawi says ‘absolute focus’ is to get 13.9 million people inoculated by mid-February Coronavirus – latest updates See all our coronavirus coverage The UK vaccine minister, Nadhim Zahawi, has pledged a “massive uplift” in the number of coronavirus vaccinations carried out this week as he said reaching the government’s target of 13.9m jabs offered …

UK vaccine minister vows ‘massive uplift’ in number of jabs this week Read More »

Analysis: is it wise for England to mix and match Covid vaccines?

US experts warn against plan to give different second jab if supplies run low Coronavirus – latest updates See all our coronavirus coverage The UK is setting the pace around the world in the approval and use of Covid vaccines but, while other countries watch intently, not all are yet prepared to embrace what looks …

Analysis: is it wise for England to mix and match Covid vaccines? Read More »

How is the Oxford Covid vaccine being deployed in England?

With jab to be administered to public for first time, we look at key questions about its rollout Coronavirus – latest updates See all our coronavirus coverage The biggest vaccination programme in the UK’s history will receive a major boost on Monday, with the first use of the Oxford/AstraZeneca Covid vaccine. We answer some key …

How is the Oxford Covid vaccine being deployed in England? Read More »

The Oxford Covid jab is delivered this week. But when will vaccines bring results?

Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain delaying second doses of vaccine? Coronavirus – latest updates See all our coronavirus coverage People in Britain are set to get their first shots of the Oxford/AstraZeneca vaccine on Monday, …

The Oxford Covid jab is delivered this week. But when will vaccines bring results? Read More »

What difference will Oxford/AstraZeneca vaccine make in UK?

We look at how the introduction of a new vaccine in the fight against Covid will work Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine is central to the government’s plans for ending social distancing in the UK and returning to some sort of normality. It has invested in seven different …

What difference will Oxford/AstraZeneca vaccine make in UK? Read More »

BioNTech criticises EU failure to order enough Covid vaccine

Firm races to fill potential gap left by bloc’s gamble on several vaccines being approved Coronavirus – latest updates See all our coronavirus coverage BioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner Pfizer to boost production amid fears of a …

BioNTech criticises EU failure to order enough Covid vaccine Read More »

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant

Many medics ‘frustrated’ about low priority given to frontline staff at high risk of infection Coronavirus – latest updates See all our coronavirus coverage Frontline NHS staff have been denied the Pfizer/BioNTech vaccine, leaving doctors alarmed and “scrabbling” to get immunised. A new survey reveals that almost two-thirds of medics who responded to it have …

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant Read More »

UK scientists trial drug to prevent coronavirus infection leading to disease

Exclusive: antibody therapy could confer instant immunity against Covid-19 to at-risk groups See all our coronavirus coverage British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives. The antibody therapy would confer instant …

UK scientists trial drug to prevent coronavirus infection leading to disease Read More »

Government ‘operated illegal buy British policy’ over Covid contracts

Other firms better placed to supply antibody tests, argues case against health secretary Matt Hancock Coronavirus – latest updates See all our coronavirus coverage The government was operating an illegal “buy British” policy when it signed contracts with a small UK firm to supply Covid antibody tests, claim lawyers who have filed a case against …

Government ‘operated illegal buy British policy’ over Covid contracts Read More »

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi

The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates See all our coronavirus coverage The UK has become the first country to approve one of the coronavirus vaccines that the entire world has been desperately waiting for. And on …

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi Read More »

Hackers accessed vaccine documents in cyber-attack on EMA

Papers relating to Pfizer/BioNTech vaccine reportedly targeted in attack on European Medicines Agency German biotech firm BioNTech said on Wednesday that regulation documents related to the Covid-19 vaccine it has developed with Pfizer were “unlawfully accessed” after a cyber-attack on Europe’s medicines regulator. Earlier, the European Medicines Agency (EMA) – which is responsible for assessing …

Hackers accessed vaccine documents in cyber-attack on EMA Read More »

Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said. The partners announced last …

Different age groups may get different Covid vaccines, experts say Read More »

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for …

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn Read More »

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd

Do not demonise. To optimise the vaccine rollout, all of us must show respect to those who are unsure about inoculations Will Hanmer-Lloyd is a behavioural strategist The Covid-19 vaccines, which are up to 95% effective, have the potential to save millions of lives in the UK and many more around the world. Yet creating …

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd Read More »

Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter Coronavirus – latest updates See all our coronavirus coverage The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most …

Vaccine results bring us a step closer to ending Covid, says Oxford scientist Read More »

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data

Trial participants react to news that Oxford AstraZeneca Covid vaccine has up to 90% efficacy Coronavirus – latest updates See all our coronavirus coverage Dan McAteer describes his reaction more as a sense of relief than elation when his phone pinged on Monday morning with a push alert reporting that the Oxford AstraZeneca vaccine has …

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data Read More »

Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our coronavirus coverage The efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest …

Oxford AstraZeneca results open up Covid vaccine to developing countries Read More »

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could stop their spread. Their insights have in turn been taken …

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial Read More »

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates See all our coronavirus coverage The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR …

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn Read More »

UK faces calls to drop opposition to patent-free Covid vaccines

Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The UK will be asked to reconsider its opposition to waiving intellectual property rights for Covid-19 vaccines and treatments at a World Trade Organization meeting on Friday, a move that would …

UK faces calls to drop opposition to patent-free Covid vaccines Read More »

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows

Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine against Covid-19 performs even better than previously thought, with 95% efficacy, equalling the early results from Moderna on Monday, according to an analysis of the final …

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows Read More »

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial Coronavirus – latest updates See all our coronavirus coverage Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials. Interim results from phase …

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab Read More »

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford, she couldn’t be persuaded into bungee jumping for all the …

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff Read More »

BioNTech vaccine scientist says jab could halve Covid transmission

Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in …

BioNTech vaccine scientist says jab could halve Covid transmission Read More »

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik

Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a strain as deadly as the 1918 influenza emerges and people’s hesitancy to get vaccinated remains at the level it is today, a debilitating and fatal disease will spread.” So wrote …

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik Read More »

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’ Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can “bash the virus over the head” and put an end …

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic Read More »

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury

Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week that the Pfizer/BioNTech vaccine protected more than 90% of recipients is of huge importance. The vaccine efficacy is higher than we had hoped for. There appear to be no safety …

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury Read More »

Pfizer/BioNTech vaccine announcement is cause for cautious celebration

Interim trial results are encouraging as scientists welcome news Coronavirus – latest updates See all our coronavirus coverage It is not yet the end of the pandemic, but the announcement by Pfizer/BioNTech that their vaccine has been 90% successful in the vital large-scale trials has got even the soberest of scientists excited. These are interim …

Pfizer/BioNTech vaccine announcement is cause for cautious celebration Read More »

What has Pfizer’s Covid vaccine trial found and is this a breakthrough?

Early results from phase 3 trial look promising but there are still many questions to be answered Coronavirus – latest updates See all our coronavirus coverage Pfizer and the German biotech company Biontech said on Monday that they had had encouraging early results from a phase 3 clinical trial of their coronavirus vaccine. The trial …

What has Pfizer’s Covid vaccine trial found and is this a breakthrough? Read More »

Oxford Covid vaccine works in all ages, trials suggest

Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups Coronavirus – latest updates See all our coronavirus coverage One of the world’s leading Covid-19 experimental vaccines produces an immune response in both older and young adults, raising hopes of a path out of the gloom and economic destruction wrought by …

Oxford Covid vaccine works in all ages, trials suggest Read More »

NHS coronavirus tests threatened by Roche supply chain glitch

Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs Coronavirus – latest updates See all our coronavirus coverage Concerns have been raised over the supply of vital testing materials for a range of conditions, including Covid-19, following a supply chain problem with the pharmaceutical company Roche. On Tuesday, Roche said it …

NHS coronavirus tests threatened by Roche supply chain glitch Read More »

Trump’s steroid Covid treatment adds to confusion over health

Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team has been to put the president on dexamethasone, a steroid that is proven, thanks to the UK’s Recovery trial, to benefit Covid-19 patients who are having breathing difficulties. But the …

Trump’s steroid Covid treatment adds to confusion over health Read More »

UK doing more than most to help poor get Covid vaccine, study finds

Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at …

UK doing more than most to help poor get Covid vaccine, study finds Read More »

Pharmacies in England pause online flu jab bookings as demand soars

Boots, LloydsPharmacy and Well Pharmacy report unprecedented take-up and many chemists run out of stock Coronavirus – latest updates See all our coronavirus coverage Pharmacies across England are struggling to keep up with the demand for the flu vaccine, pausing online bookings and limiting it to those most in need. The country’s three largest pharmacy …

Pharmacies in England pause online flu jab bookings as demand soars Read More »

Medical cannabis companies cleared for London stock market

Regulator agrees to float of UK firms but recreational suppliers still banned Medicinal cannabis companies have been cleared by the UK’s financial regulator to float on the London Stock Exchange but firms that sell marijuana to recreational users will still be banned. The Financial Conduct Authority said businesses that grow and sell recreational cannabis, even …

Medical cannabis companies cleared for London stock market Read More »

Beware of big pharma in rush for Covid-19 vaccine | Letter

Heidi Chow on why the pharmaceutical industry must not be left in the driving seat to supply an effective Covid-19 vaccine The biggest gamble that governments are taking is not on specific vaccine candidates, but on the pharmaceutical industry itself (The Covid-19 vaccine gamble: where bets have been placed and why, 11 September). The pharmaceutical …

Beware of big pharma in rush for Covid-19 vaccine | Letter Read More »

Show more empathy to boost confidence in vaccines, scientists told

Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines being developed, say experts. The temporary halting of the Oxford …

Show more empathy to boost confidence in vaccines, scientists told Read More »

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill. …

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief Read More »

GSK and Sanofi to start human trials of potential Covid-19 vaccine

World’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following promising results in earlier studies. GSK, the world’s largest vaccine …

GSK and Sanofi to start human trials of potential Covid-19 vaccine Read More »

Italian vaccine makers in race to produce flu doses before winter

Authorities order 50% more doses than in 2019 in bid to avoid hospitals being overwhelmed Coronavirus – latest updates See all our coronavirus coverage Italian vaccine manufacturers are scrambling to produce millions of flu vaccination doses amid concern there will not be enough to meet demand this autumn and winter. The country’s 20 regional authorities …

Italian vaccine makers in race to produce flu doses before winter Read More »

‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi

Russia is not the only country pursuing domestic politics over global cooperation in the fight against coronavirus We’re all waiting for a coronavirus vaccine, but when Russia announced earlier this week that it would be the first country to approve one, nobody rejoiced. Scientists pointed out clinical testing wasn’t complete, the vaccine had been tested …

‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi Read More »

UK government orders halt to Randox Covid-19 tests over safety issues

Care homes and members of public told to immediately stop using firm’s kits Coronavirus – latest updates See all our coronavirus coverage The UK government has instructed care homes and members of the public to immediately stop using coronavirus testing kits produced by a healthcare firm after safety problems were discovered. Randox was awarded a …

UK government orders halt to Randox Covid-19 tests over safety issues Read More »

Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize

Cumberlege report is a damning reminder of how arrogant, intimidating doctors have suppressed their patients’ views Julia Cumberlege’s report into avoidable harm inflicted by the healthcare system exposes an institutional inability to listen to patients in general and women in particular. Her investigation into decades of failure batters the reputation of the NHS, professional bodies, …

Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize Read More »

The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney

We need a public register to show if healthcare professionals are in the pay of industry – or more patients will suffer It was never “just women’s problems”. After decades of having their suffering dismissed, many patients will have been relieved about the publication of the Independent Medicines and Medical Devices Safety Review yesterday. Led …

The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney Read More »

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

With the NHS deal on Kaftrio, I’m likely to live longer. This is why swift access to novel treatments is so important It’s been 15 weeks since I went into isolation to shield from Covid-19 – having cystic fibrosis (CF) put me in the high-risk category. I had expected this year to be a write-off …

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

Read More »

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

Rich countries’ governments are putting all their trust in a marriage of markets and philanthropy called Gavi Vaccines for Covid-19 are coming. Billions of dollars are flowing in, over 100 efforts are under way, and at least 13 leading candidates are already being tested on humans. But how will these vaccines reach the poorest people …

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

Read More »

‘The wondrous map’: how unlocking human DNA changed the course of science

Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level Twenty years ago this week, an international group of scientists announced it had put together the first genetic blueprint of a human being. After 10 years of effort, the team – …

‘The wondrous map’: how unlocking human DNA changed the course of science Read More »

Demand for flu vaccine soars as countries plan for second Covid-19 wave

Manufacturers warn they will struggle to meet demand as governments seek to ease pressure on health services Coronavirus – latest updates See all our coronavirus coverage Fears of a second wave of coronavirus have sparked a global scramble for influenza shots from countries that hope to vaccinate great swathes of the population to reduce pressure …

Demand for flu vaccine soars as countries plan for second Covid-19 wave Read More »

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is not the time to criticise the government and its scientific …

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Read More »